Announcements

Mercia Fund Management highlights combined SEIS and EIS Funds at VCT and EIS Investor Forum
UK Government Awards 1.7M Grant To Psioxus Therapeutics For Second Phase I/II Clinical Trial Of Cancer Vaccine
Biotecnol and PolyTherics enter into a Research Collaboration for the Development of Tribody Antibody Drug Conjugates
Talking about the West Midlands European Regional Development Fund Programme
PolyTherics expands collaboration with a top five pharmaceutical company to enhance the clinical properties of biopharmaceuticals using PolyPEG
Talking university spin-outs – University of Warwick
Psioxus Launches Phase I/II Clinical Trial Of Oncolytic Vaccine With Dosing Of Patient With Metastatic Colorectal Cancer
Psioxus Therapeutics converts GBP 1 million in loan notes from the Wellcome Trust
Mercia Fund Management congratulates PsiOxus Therapeutics on Best Biotech Fund Raiser award
Pro Bono Bio obtains exclusive licence from PolyTherics